In recent years there has been a significant increase in the number of warning letters referring to ‘data integrity’ and ‘sterility assurance’ in relation to environmental monitoring. Abstract In recent years, the FDA response to companies with insufficient proof of control over their production has become more aggressive, demonstrated by the rise in 483s and…